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ABSTRACT
Objectives: In this cross-sectional study, we tested the construct validity of a “total SVD score,”
which combines individual MRI features of small-vessel disease (SVD) in one measure, by testing
associations with vascular risk factors and stroke subtype.
Methods:We analyzed data from patients with lacunar or nondisabling cortical stroke from 2 pro-
spective stroke studies. Brain MRI was rated for the presence of lacunes, white matter hyperin-
tensities, cerebral microbleeds, and perivascular spaces independently. The presence of each
SVD feature was summed in an ordinal “SVD score” (range 0–4). We tested associations with
vascular risk factors, stroke subtype, and cerebral atrophy using ordinal regression analysis.
Results: In 461 patients, multivariable analysis found that age (odds ratio [OR] 1.10, 95% confi-
dence interval [CI] 1.08–1.12), male sex (OR 1.58, 95% CI 1.10–2.29), hypertension (OR 1.50,
95% CI 1.02–2.20), smoking (OR 2.81, 95% CI 1.59–3.63), and lacunar stroke subtype (OR
2.45, 95% CI 1.70–3.54) were significantly and independently associated with the total SVD
score. The score was not associated with cerebral atrophy.
Conclusions: The total SVD score may provide a more complete estimate of the full impact of SVD
on the brain, in a simple and pragmatic way. It could have potential for patient or risk stratification
or early efficacy assessment in clinical trials of interventions to prevent SVD progression and may
(after further testing) have a useful role in clinical practice. Neurology® 2014;83:1228–1234
GLOSSARY
AF 5 atrial fibrillation; CI 5 confidence interval; CMB 5 cerebral microbleed; DWI 5 diffusion-weighted imaging; FLAIR 5
fluid-attenuated inversion recovery; OR5 odds ratio; PVS5 perivascular space; SVD5 small-vessel disease;WMH 5 white
matter hyperintensity.
Cerebral small-vessel disease (SVD) is an intrinsic disorder of the small perforating arterioles.1
SVD is a common cause of dementia and stroke, and causes considerable worsening of cognitive
function, gait, and balance.2
On brain MRI, 4 closely correlated features are markers of SVD: lacunes, white matter hyper-
intensities (WMH), cerebral microbleeds (CMBs), and visible perivascular spaces (PVS).1,2
Cerebral atrophy may also be associated with SVD.3–5 These individual SVD features are each
associated with vascular risk factors.6–9 Few studies have combined these features to capture the
“total SVD burden” or tested for associations with stroke subtype or vascular risk factors.10,11 A
total SVD burden score might capture the overall effect of SVD on the brain better than by
considering only 1 or 2 individual features separately. For example, WMH usually occur in
white matter whereas lacunes usually occur in deep gray matter; one score including both
features would reflect total brain damage better.
Recently, our Maastricht collaborative group12 developed a pragmatic estimate of total SVD
burden in patients with lacunar stroke by summing the different MRI features that were present,
yielding a 0 to 4 “total SVD score.” This total SVD score was associated with blood pressure12
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and cognition13 in patients with lacunar
stroke. This pragmatic estimate of total SVD
burden could be useful for rapid quantifica-
tion or stratification of SVD, e.g., in clinical
trials,2 genetic studies,10,11 and potentially in
clinical practice. Before wider use, further test-
ing of the score’s generalizability in larger,
more varied cohorts is required.
We investigated whether the SVD score is a
valid representation of SVD by testing
whether previously described risk factors for
individual SVD features were associated with
total SVD score, whether SVD score was high-
er in patients presenting with recent lacunar
stroke compared with cortical stroke, and
any association with cerebral atrophy.
METHODS We report our results according to the Standards
for Reporting Vascular Changes on Neuroimaging (STRIVE)
for reporting studies in SVD (www.equatornetwork.org).14 For
clarity, we refer to the clinical stroke syndrome as “lacunar
stroke,” the new acute small subcortical infarct seen on MRI as
the recent small subcortical (or lacunar) infarct, and the small
cavities that represent old lacunar infarcts as lacunes.14
Patients. We used data from 2 nonoverlapping studies of pa-
tients recruited prospectively and consecutively with lacunar or
mild cortical ischemic stroke (study 1, 2003–20077; study 2,
2010–2012, publication pending), which used very similar meth-
ods, described previously.7 These studies recruited patients with a
definite diagnosis of clinical lacunar or mild cortical ischemic
stroke who presented to the hospital stroke service (Western Gen-
eral Hospital, Edinburgh, UK) within 3 months of onset; patients
with MRI contraindications, unstable medical condition, previ-
ous stroke, and severe (i.e., disabling) stroke were excluded.
Vascular risk factors. In the primary studies, experienced physi-
cians qualified in stroke medicine recorded baseline demographics,
vascular risk factors, and other details. Hypertension (blood pres-
sure $140/90 mm Hg), diabetes mellitus (fasting blood glucose
$6.1 mmol/L), hypercholesterolemia (total cholesterol .5.0
mmol/L), ischemic heart disease (myocardial infarction, angina,
or ECG evidence of myocardial ischemia), and peripheral vascular
disease (symptoms of intermittent claudication) were defined as
previously diagnosed by a physician/general practitioner, on current
treatment, or newly diagnosed at stroke presentation. Symptomatic
carotid stenosis was defined as stenosis $50% NASCET (North
American Symptomatic Carotid Endarterectomy Trial criteria) in
the symptomatic artery, atrial fibrillation (AF) as either previous
diagnosis or AF seen on ECG, and smoking as current smoking.
Brain MRI acquisition. Patients had brain MRI on the day of
presentation (median 7; interquartile range 15 days after stroke)
on a research-dedicated 1.5T MR scanner (Signa LX; General
Electric, Milwaukee, WI) operated by research-dedicated
technical staff and which underwent daily quality assurance
monitoring. Sequences included axial diffusion-weighted
imaging (DWI), T2-weighted, fluid-attenuated inversion
recovery (FLAIR), gradient echo, and sagittal T1-weighted
sequences (for details see table e-1 on the Neurology® Web site
at Neurology.org).
Stroke subtype classification. Strokes were initially classified
into clinical lacunar or cortical stroke syndromes according to
the Oxfordshire Community Stroke Project classification.15 Final
lacunar or cortical stroke diagnosis was based on both clinical and
radiologic findings after review of all clinical and investigative
information by a panel of stroke clinical and imaging experts,
an established methodology for stroke subtype classification in
research.16 If clinical and radiologic classifications differed,17 the
radiologic classification was used. If no definite recent ischemic
lesion corresponding with the presenting symptoms was visible
on MRI, the clinical classification was used.
Standard protocol approvals, registrations, and patient
consents. Both studies were approved by the local research ethics
committee and all participants gave written informed consent.
MRI analysis. All MRIs were assessed blinded to clinical informa-
tion by one experienced neuroradiologist for the presence, location,
and size of the recent symptomatic infarct and any other vascular
lesions. A recent infarct was defined as a hyperintense area on
DWI with corresponding reduced signal on the apparent diffusion
coefficient image, with or without increased signal on FLAIR or
T2-weighted imaging, that corresponded with a typical vascular
territory.18 Recent small subcortical (lacunar) infarcts were
defined as rounded or ovoid lesions with signal characteristics as
above, .3- but ,20-mm diameter, in the basal ganglia, internal
capsule, centrum semiovale, or brainstem and carefully
distinguished from WMH.1 Cortical infarcts were defined as
infarcts involving cortical 6 adjacent subcortical tissue, or large
(.2-cm) striatocapsular/subcortical lesions.14 Lacunes were
defined as rounded or ovoid lesions, .3- and ,20-mm
diameter, in the basal ganglia, internal capsule, centrum
semiovale, or brainstem, of CSF signal intensity on T2 and
FLAIR, generally with a hyperintense rim on FLAIR and no
increased signal on DWI.14 Microbleeds were defined as small
(,5 mm), homogeneous, round foci of low signal intensity on
gradient echo images in cerebellum, brainstem, basal ganglia,
white matter, or cortico-subcortical junction, differentiated from
vessel flow voids and mineral depositions in the globi pallidi.14
Deep and periventricular WMH were both coded according to
the Fazekas scale from 0 to 3.19 We defined PVS as small (,3
mm) punctate (if perpendicular) and linear (if longitudinal to the
plane of scan) hyperintensities on T2 images in the basal ganglia or
centrum semiovale, and they were rated on a previously described,
validated semiquantitative scale from 0 to 4.7 Cerebral atrophy was
classified for both deep (enlargement of the ventricles) and
superficial (enlargement of the sulci) components on a 4-point
scale (absent, mild, moderate, severe) in study 1, and on a
modified 6-point version of the same scale in study 2.20 The
atrophy grade is determined by comparison with templates
indicating normal to atrophied brains obtained in research into
normal subjects on our scanner.20 To merge the data from both
studies, we condensed study 2’s version to 4 categories (1 absent, 2–
3 mild, 4 moderate, 5–6 severe). The intraclass correlation
coefficient for WMH intraobserver rating (100 scans) was 0.96.
The intrarater k for PVS (50 scans) was 0.80 to 0.90 (unpublished
data), for lacunes was 0.85 (unpublished data), and for microbleeds
was 0.68 to 0.78.21
Determining the total MRI burden of SVD. Based on the
recently described score,12 we rated the total MRI burden of
SVD on an ordinal scale from 0 to 4, by counting the presence
of each of the 4 MRI features of SVD. A point was awarded for
each of the following (figure): presence of lacunes and CMBs
were defined as the presence of one or more lacunes (1 point if
present) or any CMB (1 point if present). Presence of PVS was
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counted if there were moderate to severe (grade 2–4) PVS in the
basal ganglia (1 point if present). Presence of WMH was defined
as either (early) confluent deep WMH (Fazekas score 2 or 3) or
irregular periventricular WMH extending into the deep white
matter (Fazekas score 3) (1 point if present).
Because WMH are the most frequently described SVD fea-
ture in the literature,14 we tested the effect of different cutpoints
in the WMH score by lowering the cutoff of deep WMH to
Fazekas score 1, 2, or 3 (punctate or [early] confluent areas),
and of periventricular WMH to Fazekas score 2 or 3 (halo or
extending into the deep white matter). We then calculated 2
alternative total SVD scores with these lowered deep or lowered
periventricular WMH definitions.
Statistical analysis. We used x2 test and Mann–Whitney test
to test for differences between lacunar and cortical stroke. We
performed univariable ordinal regression analysis with SVD
score as dependent variable to investigate the association with
vascular risk factors and stroke subtype. We then performed
multivariable ordinal regression analysis with age, sex, stroke
subtype, risk factors that are frequently associated with individ-
ual features of SVD, i.e., hypertension, diabetes mellitus, and
smoking, and any other factor that was found to be associated in
the univariable analysis at p, 0.05. We explored the association
between deep and superficial atrophy and SVD score by univari-
able and multivariable ordinal regression analysis with correction
for age and sex and additionally for stroke subtype, hypertension,
diabetes mellitus, and smoking. Finally, we tested the effect of
the different cutoffs in the WMH score (specified above) by
performing a logistic regression analysis with stroke subtype as
dependent variable and SVD score as predictor variable, succes-
sively using the original SVD score and alternative SVD scores
with lowered cutoff points in WMH definition. Results are
presented as odds ratio (OR) with 95% confidence interval
(CI). All analyses were performed with SPSS statistics version
20 (IBM Corp., Armonk, NY).
RESULTS Of 466 patients in the original studies, 5
were excluded because of missing MRI data, leaving
461 patients for inclusion—222 patients (48%) with
lacunar stroke and 239 (52%) with cortical stroke.
We identified a symptomatic stroke lesion on
MRI in 341 patients (74%): based on DWI-
hyperintensity in 314 patients (68%) and on other
sequences in 27 (6%); in 264 of these (77%), MRI
classification matched clinical classification. In 120
patients (26%), the stroke subtype was based on
clinical findings only. Median age was 68.1 (33.8–
96.9) years; other characteristics are summarized in
table 1. Patients with lacunar stroke were younger
with lower rates of AF and symptomatic carotid
Figure Total small-vessel disease score features and categories
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stenosis than those with cortical stroke. Of the 4 MRI
features, WMH and PVS were most prevalent;
lacunar stroke patients more often had lacunes and
PVS (table 1).
Total SVD score. Of the patients who scored 1, most
(45%) had PVS, followed by WMH (29%), lacunes
(15%), and CMBs (11%) (table 2). Of those who
scored 2, all combinations were present, but the com-
bination of PVS andWMHwas predominant (64%).
Of those who scored 3, all potential combinations
were present, but PVS 1 WMH 1 lacunes (43%)
and PVS 1WMH 1 CMBs (44%) were most prev-
alent. Lacunar stroke patients had higher ratings of
SVD burden compared with cortical stroke patients
(table 2; p 5 0.001).
Association with vascular risk factors and stroke subtype.
In univariable analysis, total SVD score was signifi-
cantly associated with age (OR 1.07, 95% CI 1.06–
1.09 per year), male sex (OR 1.44, 95% CI 1.02–
2.03), peripheral vascular disease (OR 2.46, 95% CI
1.15–5.30), hypertension (OR 1.82, 95% CI 1.28–
2.60), and lacunar stroke subtype (OR 1.73, 95% CI
1.24–2.41), but not with diabetes, smoking, hyper-
cholesterolemia, ischemic heart disease, AF, sympto-
matic carotid stenosis, or family history of stroke.
On multivariable analysis (table 3), age (OR 1.10,
95%CI 1.08–1.12), male sex (OR 1.58, 95%CI 1.10–
2.29), hypertension (OR 1.50, 95% CI 1.02–2.20),
smoking (OR 2.81, 95% CI 1.59–3.63), and lacunar
stroke subtype (OR 2.45, 95% CI 1.70–3.54) were
significantly and independently associated with total
SVD score, the association for smoking and lacunar
stroke subtype becoming stronger in multivariable than
in univariable testing. The results were similar for just
those patients with a DWI-visible recent stroke lesion.
Association between total SVD score and cerebral atrophy.
Both deep and superficial atrophy were significantly
Table 1 Clinical and radiologic characteristics of the study population
All patients (n 5 461) Lacunar stroke (n 5 222) Cortical stroke (n 5 239)
Age, y 68.1 (33.8–96.9) 66.3 (34.7–96.9) 69.7 (33.8–92.1)a
Male sex 286 (62) 130 (59) 156 (65)
Ischemic heart disease 90 (20) 35 (16) 55 (23)
Peripheral vascular disease 22 (5) 8 (4) 14 (6)
Diabetes mellitus 59 (13) 32 (14) 27 (11)
Hypertension 300 (65) 137 (62) 163 (68)
Smokingb 148 (33) 80 (37) 68 (29)
Hypercholesterolemiab 210 (46) 96 (44) 114 (48)
Symptomatic carotid stenosis ‡50%b 41 (9) 9 (4) 32 (14)a
Atrial fibrillation 50 (11) 15 (7) 35 (15)a
Family history of strokeb 113 (25) 56 (26) 57 (24)
MRI features
Lacunes 94 (20) 63 (28) 31 (13)a
WMH 170 (37) 84 (38) 86 (36)
CMBs 71 (15) 40 (18) 31 (13)
PVS 209 (45) 116 (52) 93 (39)a
Cerebral atrophy
Deep atrophy 1 (0–3) 1 (0–3) 1 (0–3)
Superficial atrophy 1 (0–3) 1 (0–3) 1 (0–3)
Abbreviations: CMB 5 cerebral microbleed; PVS 5 perivascular spaces; WMH 5 white matter hyperintensities.
Data presented as number (%) or median (range).
ap , 0.05 cortical vs lacunar stroke.
bNine missing in smoking; 2 missing in hypercholesterolemia; 27 missing in symptomatic carotid stenosis; 13 missing in
family history of stroke.
Table 2 Total SVD score values for all patients and by stroke subtype
SVD score All patients (N 5 461) Lacunar stroke (n 5 222) Cortical stroke (n 5 239)
0 181 (39) 73 (33) 108 (45)
1 112 (24) 53 (24) 59 (25)
2 88 (19) 48 (22) 40 (17)
3 64 (14) 38 (17) 26 (11)
4 16 (4) 10 (4) 6 (2)
Abbreviation: SVD 5 small-vessel disease.
Data presented as number (%). Mann–Whitney test lacunar vs cortical stroke, p 5 0.001.
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associated with SVD burden in unadjusted analyses
(table 4). After fully adjusting for age, sex, and vascular
risk factors, the association with superficial atrophy was
only marginally significant, and the association of deep
atrophy with SVD score became nonsignificant.
Total SVD score with alternative cutpoints of WMH.
With stroke subtype as the dependent variable, total
SVD score was associated with lacunar vs cortical
stroke subtype (OR 1.29, 95% CI 1.10–1.51). Vary-
ing the cutoff point in the definition of WMH
improved the OR of the total SVD score for predict-
ing lacunar stroke subtype only slightly to a maximal
OR of 1.39 (95% CI 1.16–1.37) (see table e-2).
DISCUSSION We showed that total SVD score has
construct validity. We validated the initial version of
the score12,13 in a much larger, diverse cohort. The
score was higher in patients presenting with acute lacu-
nar stroke compared with acute cortical stroke, and was
also associated with age, male sex, smoking, and hyper-
tension. Hypertension was considered to be the stron-
gest vascular risk factor for SVD previously; blood
pressure level was also associated with total SVD score
in a smaller study.12 An important finding in the pre-
sent work using the total SVD score is that smoking
also was an important modifiable risk factor; the asso-
ciation between smoking and total SVD score was
stronger than had been seen previously with individual
SVD features. Smoking has been associated with both
WMH22 and reduced microstructural integrity of
white matter,23 less consistently with CMBs and la-
cunes,9,24 and not with PVS.7
Regarding other risk factors, diabetes is often re-
ported as a risk factor for SVD, but it is equally com-
mon in small-vessel and large-vessel stroke25 and
many studies found no association between diabetes
and any of the MRI features,8,9,26,27 nor did we find an
association with total SVD score. Former results
regarding sex varied, some studies reporting a male,
others a female preponderance for SVD features,
while others did not find an association.8,9,24,27
Although clinical classification of stroke subtype in
the absence of a recent MRI infarct may introduce
some diagnostic uncertainty and bias, the association
between higher total SVD score and lacunar (vs cor-
tical) stroke subtype was also present when selecting
only those patients with a DWI-visible acute infarct
(68%; results not shown).
The total SVD score could be helpful for baseline
stratification or as a surrogate marker for SVD in pre-
vention and therapeutic trials if further testing con-
firms our results. The score provides a more
complete overall view of the impact of SVD on the
brain than do the individual MRI features separately.
It is a simple and pragmatic visual score and allows for
easy comparison and combination of data as long as
standardized definitions of the individual features
are adopted.14 Some may argue that there are differ-
ences in the underlying pathogenetic mechanism
leading to these different SVD features. However,
all of these MRI features are considered to result from
disease in the small vessels, and they often co-occur.
Our approach was to compile the overall brain dam-
age resulting from SVD, not the underlying path-
ways. The score could be used to define patients
that are at risk of (lacunar) stroke,28 e.g., for stratify-
ing patients in secondary prevention trials. The use-
fulness of considering the whole spectrum of SVD
abnormalities has also been shown in genetic
Table 3 Associations with total SVD score in
multivariable ordinal regression
analysis
OR (95% CI)
Age (per year) 1.10 (1.08–1.12)a
Male sex 1.58 (1.10–2.29)b
Diabetes mellitus 0.98 (0.57–1.67)
Hypertension 1.50 (1.02–2.20)b
Smoking 2.81 (1.59–3.63)a
Peripheral vascular disease 1.64 (0.75–3.61)
Lacunar stroke 2.45 (1.70–3.54)a
Abbreviations: CI 5 confidence interval; OR 5 odds ratio;
SVD 5 small-vessel disease.
Multivariable analysis with correction for all variables in the
table. Because of missing variables, n5 452 in the analysis.
ap , 0.001.
bp , 0.05.
Table 4 Association between cerebral atrophy and total SVD score
Unadjusted OR (95% CI) Age- 1 sex-adjusted OR (95% CI) Fully adjusteda OR (95% CI)
Deep atrophy 1.81 (1.52–2.16)b 1.26 (1.03–1.55)c 1.23 (0.99–1.52)
Superficial atrophy 2.22 (1.78–2.78)b 1.41 (1.09–1.83)d 1.31 (1.01–1.71)c
Abbreviations: CI 5 confidence interval; OR 5 odds ratio; SVD 5 small-vessel disease.
aAdjusted for age, sex, stroke subtype, hypertension, diabetes mellitus, and smoking. Because of missing variables,
n 5 542 in this analysis.
bp , 0.001.
cp , 0.05.
dp , 0.01.
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studies.10 The score might also be useful, after further
validation, in clinical practice, for example, to identify
subjects at risk of cognitive decline and physical im-
pairments, although currently this would be by
extrapolation from studies on the individual fea-
tures2,29–31 and not yet formally tested for the total
SVD score. Further prospective studies are required
to validate these suggestions.
Further developments of the proposed “total SVD
score” would be testing other weightings and different
cutpoints for different SVD features, and greater
granularity for features that are currently only dichot-
omized as yes–no, e.g., lacunes and CMBs. Different
cutpoints and weightings could be tested for PVS and
WMH; the present ones may not be optimal. For
example, punctate deep WMH (Fazekas score 1)
and a periventricular halo (Fazekas score 2) were
below the cutpoint definition of WMH in the present
total SVD score. We tried alternative lowered cut-
points for WMH, but these led to only slightly better
performance of the SVD score—larger, more diverse
datasets are required to test cutpoints more thor-
oughly. The cutoff for WMH in the original SVD
score was chosen because those Fazekas scores were
related to SVD in a small histopathology study12,32
from 2 decades ago, despite which it seems to perform
reasonably well in the current study.
Cerebral atrophy is sometimes considered another
MRI feature of SVD.14 While many studies report an
association between atrophy and SVD,4,5,33 it is not
specific to SVD, occurring in many other conditions
including normal aging. We found only a weak asso-
ciation between superficial atrophy and total SVD
score, but we may have introduced some inconsis-
tency by combining 2 slightly different visual scoring
methods. Alternatively, the association with atrophy
may apply more in older populations or at different
stages of SVD, or volumetric measurements of brain
volume might be needed to explore this issue further.
For now, there is no strong case for including atrophy
in the total SVD score.
A limitation of our study is the cross-sectional
design: longitudinal studies are required to explore
the predictive ability of total SVD score and progres-
sion of MRI features, cognitive decline, and (recurrent)
stroke risk, and to have more robust evidence that it
can be used as an SVD predictor in trials, although
the analysis presented here justifies its use to stratify pa-
tients according to SVD burden at randomization. A
strength is the use of a recently published standard
for describing imaging findings in SVD.14 Other stud-
ies using the score must ensure that the same defini-
tions of the individual SVD features are used. The total
SVD score needs further testing in independent large
cohorts, with varied risk factor profiles and ethnicity, to
determine its generalizability and whether different
cutpoints and weighting of individual SVD features
might improve the score’s performance. We also sug-
gest testing in other consequences of SVD, such as
cohorts with vascular cognitive impairment and
dementia, or intracerebral hemorrhage.
We found that the risk factors for SVD—smoking,
hypertension, age, and male sex—are associated with
the total summed SVD score of individual MRI
features. This score avoids overreliance on individual
MRI features and provides a more complete view of
SVD. It has potential application as a risk stratification
for SVD in clinical trials or other clinical research and
may (after further testing) have a useful role in clinical
practice.
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